Student Work

 

Drug Synthesis for HCV Public

Downloadable Content

Download PDF

The hepatitis C virus infects more than 170 million people worldwide. Many of the HCV deaths have been a result of drug resistance. It is essential for researchers to continue to modify the molecules to create a greater variety of drug analogues, and in doing so create one that is the solution to the HCV epidemic. HCV drug analogs that lack a side chain are less hindered and more adaptable in fighting the mutant virus; drugs of this molecular form should be focused on to produce an optimal drug response to the virus.

Creator
Publisher
Identifier
  • E-project-042612-141254
Advisor
Year
  • 2012
Date created
  • 2012-04-26
Resource type
Major
Rights statement
License

Relationships

In Collection:

Items

Permanent link to this page: https://digital.wpi.edu/show/p2676x443